Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

Pulmonary arterial hypertension is a rare disease, with drug-induced causes even more uncommon, accounting for only 10% of cases in large registry series. Predisposing factors for drug-induced PAH have not been completely defined. This review summarizes drugs with definite, possible, or likely assoc...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy Vol. 33; no. 6; pp. 725 - 738
Main Authors: Correale, Michele, Tricarico, Lucia, Grazioli, Davide, Formica, Ennio Sascia, Petrucci, Rossella, Persichella, Paola, Di Biase, Matteo, Brunetti, Natale Daniele
Format: Journal Article
Language:English
Published: New York Springer US 01.12.2019
Springer Nature B.V
Subjects:
ISSN:0920-3206, 1573-7241, 1573-7241
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulmonary arterial hypertension is a rare disease, with drug-induced causes even more uncommon, accounting for only 10% of cases in large registry series. Predisposing factors for drug-induced PAH have not been completely defined. This review summarizes drugs with definite, possible, or likely association to pulmonary hypertension and possible mechanisms involved in the occurrence of pulmonary hypertension. Controversies on mechanisms and on their role in pathophysiology were also shown. The possible synergism between drug abuse and HIV was discussed and the possible interactions of antiretroviral therapy in HIV subjects were analyzed. Furthermore, we reported clinical findings and possible management, specific for each class of drugs, in case of drug-induced PAH. Finally, we summarized into a unified algorithm possible management of drug-induced PAH.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0920-3206
1573-7241
1573-7241
DOI:10.1007/s10557-019-06920-x